ACADIA Pharmaceuticals Inc. vs Southwest Airlines Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Southwest Airlines Co trades at $45.21 (market cap $22.27B). The key difference: Southwest Airlines Co is far larger — about 4.4× ACADIA Pharmaceuticals Inc.'s market cap, and Southwest Airlines Co pays a 1.58% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | LUV | |
|---|---|---|
Market Cap | $5.07B | $22.27B |
Sector | Health | Industrials |
52-Week High | $29.41 | $54.80 |
52-Week Low | $20.06 | $29.67 |
Enterprise Value | $4.19B | $25.37B |
Dividend Yield | — | 1.58% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →